EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience

Nargiz Majidova, Murat Sarı, Fatma Akdag Kahvecioglu, Erkan Ozcan, Mutıianur Ozkorkmaz Akdag, Akif Dogan, Sedat Yıldırım, Sermin Dinc Sonusen, Emil Yunusov, Alper Yasar, Abdussamet Celebi, Nadiye Sever und 12 weitere

Oncology Research and Treatment · 2024

DOI: 10.1159/000537988 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Oncology Research and Treatment, 2024. Verfasst von Nargiz Majidova und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey, nergiz.mecidova1991@gmail.com. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Induction Chemotherapy, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Nasopharyngeal carcinoma (NPC) accounts for 0.01% of all carcinomas, and 70% of patients have locally advanced disease with a poor prognosis. The mainstay therapy is chemoradiotherapy (CRT), and concurrent administration of platinum-based agents and irradiation provides high local control rates. However, induction (neoadjuvant) chemotherapy (ICT) prior to CRT is recommended for large tumors with a high tumor burden at the category 1 level. For ICT, platinum-based doublet or triplet combination regimens are recommended. Selected patients with a high tumor burden at the time of diagnosis who did not receive ICT before CRT were given adjuvant (consolidation) therapy after CRT. This multicenter study aimed to share our experience in treatment of NPC and evaluate the factors associated with survival.

Methods

The study included patients diagnosed with NPC who were followed and treated between 2008 and 2022. Hundred and forty-two patients from 6 centers were evaluated. The factors associated with disease-free survival (DFS) and overall survival (OS) were evaluated.

Results

The median age of our patients was 51 years (IQR: 16–81 years), and the male:female ratio was 2.5:1. A majority of patients (71%) had stage 3–4 disease. They had locally advanced disease, and 48 patients (34%) received ICT. Twenty patients (14%) received adjuvant therapy. The median follow-up was 41 months (range, 2.7–175.1 months). The median DFS in NPC was 92.6 months (range, 71.9–113.3 months), with a 40th month DFS of 70.9%. The median OS was 113 months (range, 91–135 months), with a 40th month OS of 84.7%. Median DFS was 95.3 months (range, 64.2–126.4 months) in patients who received ICT before CRT, which was longer than in the CRT-only group (p = 0.6). DFS at the 40th month was 75.1% in patients treated with ICT compared to 65.1% in the CRT-only group. Median OS was 117 months (range, 92–142 months) in patients receiving ICT, which was longer than in the CRT-only group (p = 0.4). OS at the 40th month was 86.7% in patients receiving ICT but 83.6% in the CRT-only group.

Conclusions

Both the objective response rate and survival were longer in patients who radiologically responded to CRT following ICT. Nonresponse to ICT is a negative predictive indicator. The role of ICT in locally advanced NPC is increasing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaInduction ChemotherapyNasopharyngeal NeoplasmsHumansMaleFemaleMiddle AgedAdultAgedYoung AdultAdolescentAged, 80 and overChemoradiotherapyTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesDisease-Free SurvivalNeoadjuvant TherapyNeoplasm Staging

Stichwörter der Autor:innen

ChemoradiotherapyInduction chemotherapyNasopharyngeal carcinoma

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey, nergiz.mecidova1991@gmail.com.
  • Division of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Division of Medical Oncology, Department of Internal Medicine, Sakarya University School of Medicine, Adapazari, Turkey.
  • Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
  • Division of Medical Oncology, Department of Internal Medicine, Kocaeli University, İzmit, Turkey.
  • Division of Medical Oncology, Department of Internal Medicine, Istanbul Kartal Lutfi Kirdar Education and Training Hospital, Istanbul, Turkey.

Zitieren

APA

Majidova, N., Sarı, M., Kahvecioglu, F. A., Ozcan, E., Akdag, M. O., Dogan, A., Yıldırım, S., Sonusen, S. D., Yunusov, E., Yasar, A., Celebi, A., Sever, N., Kocaaslan, E., Erel, P., Agyol, Y., Guren, A. K., Arıkan, R., Isık, S., Balvan, O., …, & Bayoglu, I. V. (2024). Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience. Oncology Research and Treatment. https://doi.org/10.1159/000537988

Vancouver

Majidova N, Sarı M, Kahvecioglu FA, Ozcan E, Akdag MO, Dogan A, et al. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience. Oncology Research and Treatment. 2024. doi:10.1159/000537988

BibTeX
@article{Majidova2024,
  author = {Majidova, Nargiz and Sarı, Murat and Kahvecioglu, Fatma Akdag and Ozcan, Erkan and Akdag, Mutıianur Ozkorkmaz and Dogan, Akif and Yıldırım, Sedat and Sonusen, Sermin Dinc and Yunusov, Emil and Yasar, Alper and Celebi, Abdussamet and Sever, Nadiye and Kocaaslan, Erkam and Erel, Pınar and Agyol, Yesım and Guren, Alı Kaan and Arıkan, Rukıye and Isık, Selver and Balvan, Ozlem and Geredelı, Caglayan and Uygun, Kazım and Hacibekiroglu, Ilhan and Kostek, Osman and Bayoglu, Ibrahım Vedat},
  title = {Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience},
  journal = {Oncology Research and Treatment},
  year = {2024},
  doi = {10.1159/000537988}
}
Kostenlos starten →